Navigation Links
Scott & White Healthcare and American Cancer Society enter into partnership for prevention study

TEMPLE, Texas (Tuesday, October 25, 2011) - Today, Scott & White Healthcare and the American Cancer Society have announced a joint collaboration for the Cancer Prevention Study 3 (CPS-3), the first study of its kind in more than 20 years. The American Cancer Society CPS-3 study is enrolling at least 300,000 adults from various racial/ethnic backgrounds from across the U.S., to better understand how to prevent the disease.

Scott & White Healthcare is the first, and to date only, health system to form such a partnership with the American Cancer Society (Society) High Plains Division which covers a six-state area (TX, OK, MO, NE, KS, and HI). Scott & White will host enrollment sites and recruit community members to join the study and the Society will follow these participants for 20-30 years. Enrollment sites will be at Scott & White hospitals in Temple, Waco, and Round Rock, and potentially other locations at a later date. The enrollment period will be from late March until early April 2012.

Men and women between the ages of 30 and 65 years who have no personal history of cancer are invited to join this historic research study. The first CPS study, conducted in the 1950s, discovered the link between cigarette smoking and lung cancer. The second such study which began in the 1980s and is still ongoing determined the link between obesity and the risk of cancer occurrence. CPS-3 will give researchers the ability to examine how not only lifestyle impacts cancer risk but genetic factors, hormonal factors and other markers in the blood that are also related to the development, or prevention, of cancer.

"This partnership is another milestone in our journey to becoming an NCI-designated cancer institute," said Andrejs E. Avots-Avotins, M.D., Ph.D., chairman of the Board of Directors at Scott & White Healthcare, and member of the Board of Directors of the Society's High Plains Division.

"There are millions of people who have avoided a diagnosis of cancer because of the results of our first two prevention studies. This new study will help us determine how behaviors and lifestyles might lead to cancer," said Mike Dany, CEO of the Society's High Plains Division. "Currently, there are no other studies of this magnitude in the U.S. that enable researchers to look at various racial and ethnic populations and cancer risk."

The Scott & White Cancer Institute, which includes the Vasicek Cancer Treatment Center in Temple, offers highly-specialized and coordinated care throughout the entire Scott & White system. Patients and families have one-stop access to cancer diagnosis and treatment, backed by medical research and education. The Cancer Research Institute (CRI), a non-profit arm of the Scott & White Cancer Institute, accelerates the development of new therapies for human diseases. Universities, investigators, foundations and companies bring their discoveries to the CRI to complete the steps for introducing new treatments to the clinic.

"Collaborating with The American Cancer Society is an important step forward for the Scott & White Cancer Institute, the people of Central Texas and the nation in our shared fight against cancer," said Subhakar Mutyala, M.D., director of the Scott & White Cancer Institute and chairman of the department of radiation oncology.


Contact: Katherine Voss
Scott & White Healthcare

Related medicine news :

1. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
2. Scott & White Healthcare pathologist is co-investigator on breast cancer study
3. James Scott Farrin Supports Radiothon for Duke Children's Hospital
4. SUNZ Insurance Company Selects Scott Robertson as President
5. Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona
6. Scott & White Healthcare researchers studying investigational agent that targets breast cancer
7. New Varicose Vein Treatment Center Opens in Prescott, Arizona
8. Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages
9. Scott & White Healthcare clinical trials target lymphoma, leukemia
10. Scott & White Healthcare physician to help develop global guidelines for Alzheimers
11. Scott Harter at Atrion International Receives EHS Gold Award From PPG Industries
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: